PFE vs PTGX · P/E 20, rev $15.03B vs rev $269.8M
Pfizer Inc (PFE) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla D.V.M., Ph.D..
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the PFE and PTGX stock pages for the full models.
Not investment advice.